Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 280-427-9 | CAS number: 83400-12-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 9, 1992 to October 19, 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- EEC Directive 84/449/EEC B.14. Other Effects – Mutagenicity Salmonella typhimurium Reverse Mutation Test
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- OECD Guidelines for Testing of Chemicals “Genetic Toxicology: Salmonella typhimurium, Reverse Mutation Assay" Adopted: 26 May 83, No. 471
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: US EPA - HG - Gene Muta - S. typhimurium, October 1984
- Version / remarks:
- New and Revised Health Effects Test Guidelines October 1984. (U.S.) Environmental Protection Agency Washington, DC (PB 84-233295).
HG - Gene Muta - S. typhimurium, October 1984 - Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: M. J. Prival, V. D; Mitchell
- Version / remarks:
- M. J . Prival, V. D. Mitchell: Analysis of a method for testing azo dyes for mutagenicity in Salmonella typhimurium in the presence of flavine mononucleotide and hamster liver S-9. Mut. Res., 103- 106 (1982).
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 4-(benzoylamino)-6-[[5-[[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]methyl]-1-sulpho-2-naphthyl]azo]-5-hydroxynaphthalene-1,7-disulphonic acid, lithium sodium salt
- EC Number:
- 280-426-3
- EC Name:
- 4-(benzoylamino)-6-[[5-[[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]methyl]-1-sulpho-2-naphthyl]azo]-5-hydroxynaphthalene-1,7-disulphonic acid, lithium sodium salt
- Cas Number:
- 83400-11-7
- Molecular formula:
- C32 H21 Cl F2 N6 O11 S3 . x Li . x Na C32H(21-x-y)ClF2Li(x)N6Na(y)O11S3
- IUPAC Name:
- lithium sodium 4-benzamido-6-[2-(5-{[(5-chloro-2,6-difluoropyrimidin-4-yl)amino]methyl}-1-sulfonatonaphthalen-2-yl)diazen-1-yl]-5-hydroxynaphthalene-1,7-disulfonate
- Test material form:
- solid: particulate/powder
- Details on test material:
- Reactive Red 158
Constituent 1
Method
- Target gene:
- Histidine
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- The doses for the first trial were routinely determined on the basis of a standard protocol: if not limited by solubility 5000 μg or 5 μl per plate were used as the highest dose.
The results of the first plate incorporation experiment was considered a pre-test for toxicity.
Doses of repeats for the plate incorporation test were chosen on the basis of the results obtained in the first experiment.
The doses of the preincubation test trial were determined on the basis of the results of the plate incorporation assay.
0, 8, 40, 200, 1000, 5000 μg/plate - Plate incorporation test
0, 8, 40, 200, 1000, 5000 μg/tube - Preincubation test
The doses for the first trial were routinely determined on the basis of a standard protocol: if not limited by solubility 5000 μg or 5 μl per plate were used as the highest dose. The following doses were used for the first trial (plate incorporation test): 0, 8, 40, 200, 1000, 5000 μg/plate.
The doses of the preincubation test were determined on the basis of the results of the plate incorporation test. In the plate incorporation test, there was no indication of a bacteriotoxic effect of C.I. Reactive Red 158 at doses of up to and including 200 µg per plate. Higher doses had a weak, strain-specific bacteriotoxic effect, but could nevertheless be used for assessment up to and including 5000 µg per plate. Therefore, the following doses were used for the second trial (preincubation test): 0, 8, 40, 200, 1000, 5000 μg/tube. - Vehicle / solvent:
- C.I. Reactive Red 158 was dissolved in deionized water.
The solvent used was chosen out of the following solvents, in the order given: water, methanol, ethanol, acetone, DMSO, DMF, and ethylene glycol dimethylether according to information given by the internal sponsor.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- congo red
- other: Nitrofurantoin (NF); 4-nitro-1,2-phenylene diamine (4-NOPD); 2-aminoanthracene (2-AA); Benzadine
- Details on test system and experimental conditions:
- The initial plate incorporation test followed the directions of Ames et al. (1973a, 1975) and Maron and Ames (1983).
For the mutant count, four plates were used, both with and without S9 mix, for each strain and dose. An equal number of plates, filled with the solvent minus the test substance, comprised the negative control. Each positive control also contained four plates per strain. The amount of solvent for the test substance and for the controls was 0.1 ml/plate.
The doses for the first trial were routinely determined on the basis of a standard protocol: if not limited by solubility 5000 μg or 5 μl per plate were used as the highest dose. At least four additional doses were routinely used as progressive dilutions of the top dose. If less than three doses were used for assessment, at least two repeats were performed. The results of the first experiment were then considered a pre-test for toxicity. However, in case of a positive, response or if at least three doses could be used for assessment, the first trial was included in the assessment. If the second test confirmed the results of the first, no additional repeat was performed. Doses of repeats were chosen on the basis of the results obtained in the first experiment.
Because the first assessable trial showed no mutagenic effects of the test substance, the repeat was performed according to Prival and Mitchell (1982) due to the chemical structure of the compound. Preincubation was performed in a water bath at 30 °C for 30 minutes. At the end of the pre-incubation period 2 ml of molten soft agar were added to the tubes, the content mixed and plated.
For the mutant count, four plates were used for each strain and dose. An equal number of plates, filled with the solvent minus the test substance, comprised the negative control. Each positive control also contained four plates per strain. In experiments without S9 mix buffer was used as replacement.
The doses of this trial were determined on the basis of the results of the plate incorporation assay.
The toxicity of the substance was assessed in three ways. The first method was a gross appraisal of background growth on the plates for mutant determination. Secondly, a toxic effect of the substance was assumed when there was a marked and dose-dependent reduction in the mutant count per plate, compared to the negative controls. Thirdly, the titer was determined. Total bacterial counts were taken on two plates for each concentration studied with S9 mix. However, if an evaluation was performed only without S9 mix, the bacterial count was taken without S9 mix.
The bacterial suspensions were obtained from 17-hour cultures in nutrient broth, which had been incubated at 37 °C and 90 rpm. These suspensions were used for the determination of mutant counts. No standardized procedure was employed to set the bacterial suspensions at a defined density of viable cells per millilitre, since the chosen method of incubation normally produces the desired density. However, the numbers of viable cells were established in a parallel procedure by determining the titers.
The dilution of bacterial suspensions used for the determination of titers was 1:1,000,000. Titers were determined under the same conditions as were the mutations, except that the histidine concentration in the soft agar was increased fivefold to permit the complete growth of bacteria.
The tests were performed both with and without S9 mix.
The count was made after the plates had been incubated for 48 hours at 37 °C. If no immediate count was possible, plates were temporarily stored in a refrigerator.
The following criteria determined the acceptance of an assay:
a) The negative controls had to be within the expected range, as defined by published data (e.g. Maron and Ames, 1983) and/or the laboratories' own historical data.
b) The positive controls had to show sufficient effect as defined by the laboratories' experience.
c) Titer determinations had to demonstrate sufficient bacterial density in the suspension.
An assay which did not comply with at least one the above criteria was not used for assessment. Furthermore, the data generated in this assay needed to be confirmed by two additional independent experiments. Even if the criteria for points (a), (b) and (C) were not met, an assay was accepted if it showed mutagenic activity of the test compound.
The following doses per plate were evaluated:
μg per plate
1. Negative control 0
2. C.I. Reactive Red 158 5000
3. C.I. Reactive Red 158 1000
4. C.I. Reactive Red 158 200
5. C.I. Reactive Red 158 40
6. C. I. Reactive Red 158 8
7. Positive control, sodium azide 10 (only TA 1535)
8. Positive control, nitrofurantoin 0.2 (only TA 100)
9. Positive control, 4-nitro-1,2-phenylene diamine 10 (only TA 1537)
10. Positive control, 4-nitro-1,2-phenylene diamine 0.5 (only TA 98)
11. Positive control, 2-aminoanthracene 3
12. Positive control, benzidine 4 (only TA 98)
13. Positive control, Congo red 50 (only TA 98)
The solvent employed for Congo red was deionized water, and for the other positive controls DMSO. C.I. Reactive Red 158 was dissolved in deionized water.
No "untreated" negative control was set up for deionized water, since sufficient evidence was available in the literature (e.g. Maron and Ames, 1983) and from the laboratories own experience, indicating that this solvent had no influence on the spontaneous mutant counts of the bacterial strains used. - Rationale for test conditions:
- The initial plate incorporation test followed the directions of Ames et al. (1973a, 1975) and Maron and Ames (1983).
Because the first assessable trial showed no mutagenic effects of the test substance, the repeat was performed according to Prival and Mitchell (1982) due to the chemical structure of the compound - Evaluation criteria:
- A reproducible and dose-related increase in mutant counts of at least one strain is considered to be a positive result.
For TA 1535, TA 100 and TA 98 this increase should be about twice that of negative controls, whereas for TA 1537, at least a threefold increase should reached. Otherwise, the result is evaluated as negative However, these guidelines may be overruled by good scientific judgement.
In case of questionable results, investigations should continue, possibly with modifications, until a final evaluation is possible. - Statistics:
- None
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In first test, doses ≥ 1000 µg per plate and, in the second test, doses ≥ 200 μg/tube, had a strain-specific bacteriotoxic effect.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In first test, doses ≥ 1000 µg per plate and, in the second test, doses ≥ 200 μg/tube, had a strain-specific bacteriotoxic effect.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In first test, doses ≥ 1000 µg per plate and, in the second test, doses ≥ 200 μg/tube, had a strain-specific bacteriotoxic effect.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- In first test, doses ≥ 1000 µg per plate and, in the second test, doses ≥ 200 μg/tube, had a strain-specific bacteriotoxic effect.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- Plate Incorporation Method
There was no indication of a bacteriotoxic effect at doses of up to and including 200 μg per plate. The total bacteria counts consistently produced results comparable to the negative controls, or differed only insignificantly. No inhibition of growth was noted as well. Higher doses had a weak, strain-specific bacteriotoxic effect, but could nevertheless be used for assessment up to and including 5000 μg per plate.
None of the four strains concerned showed a dose-related and biologically relevant increase in mutant counts over those of the negative controls. This applied both to the tests with and without S9 mix.
The positive controls sodium azide, nitrofurantoin, 4-nitro-1,2-phenylene diamine and 2-aminoanthracene increased mutant counts to well over those of the negative controls, and thus demonstrated the system's sensitivity and the activity of the S9 mix.
Prival Assay
There was no indication of a bacteriotoxic effect at doses of to and including 40 μg per tube. The total bacteria counts consistently produced results comparable to the negative controls, or differed only insignificantly. No inhibition of growth was noted as well. Higher doses had a strain-specific bacteriotoxic effect, and could only partly be used for assessment up to and including 5000 μg per tube.
None of the four strains concerned showed a dose related and biologically relevant increase in mutant count over those of the negative controls and thus confirmed the results of the plate incorporation method.
The positive controls sodium azide, nitrofurantoin, 4-nitro-1,2-phenylene diamine, benzidine, Congo red and 2-aminoanthracene increased mutant counts to well over those of the negative controls, and thus demonstrated the system's sensitivity and the activity of the S9 mix.
Any other information on results incl. tables
Summary of the Results in the
Salmonella/Microsome Test Plate Incorporation Method
S9 mix |
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
Without |
-ve |
-ve |
-ve |
-ve |
With |
-ve |
-ve |
-ve |
-ve |
-ve = negative
Summary of the Results in the
Salmonella/Microsome Test Prival Assay
S9 mix |
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
Without |
-ve |
-ve |
-ve |
-ve |
With |
-ve |
-ve |
-ve |
-ve |
-ve = negative
Summary of Mean Values Without S9 Mix
Group |
Strain |
|
|
|
|
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
μg/plate 0 8 40 200 1000 5000 Na-azide NF 4-NPDA |
14 13 12 15 12 11 695 |
52 72 76 73 63 42
260 |
10 8 9 11 7 3
56 |
21 27 24 19 23 9
143 |
μg/tube 0 8 40 200 1000 5000 Na-azide NF 4-NPDA |
12 13 14 13 11 15 784 |
71 79 62 49 67 55
223 |
10 10 12 11 11 8
49 |
12 16 19 18 20 17
54 |
Summary of Mean Values With S9 Mix
Group |
Strain |
|
|
|
|
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
μg/plate 0 8 40 200 1000 5000 2-AA |
21 18 20 21 16 12 143 |
100 112 115 117 138 56 386 |
23 22 18 17 13 14 77 |
34 37 43 45 42 24 402 |
μg/tube 0 8 40 200 1000 5000 Benzidine Congo red 2-AA |
19 13 16 19 14 12
101 |
133 151 144 140 135 84
892 |
20 23 16 18 16 10
187 |
39 32 29 26 24 22 103 71 |
Summary of historical negative and positive controls of experiments performed from January to June 1991 using mean value presented as medians (Z) and semi-Q range (QR)
Compound and S9 Mix |
Strain |
||||||||
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
||||||
Z |
QR |
Z |
QR |
Z |
QR |
Z |
QR |
||
Water DMSO DMF Methanol Ethanol Acetone EGDE2 |
- - - - - - - |
12 13 9 11 12 10 11 |
3 2 - 2 1 - 3 |
111 113 80 105 96 55 108 |
10 14 -- 14 15 -- 5 |
9 10 7 8 9 5 8 |
2 2 - 2 2 - 1 |
28 30 23 29 31 21 23 |
5 3 - 5 5 - 8 |
Na-azide NF 4-NPDA |
- - - |
623 |
102 |
398 |
56 |
49 |
10 |
89 |
20 |
30% Water DMSO DMF Methanol Ethanol Acetone EGDE2 |
+ + + + + + + |
16 18 11 23 19 14 15 |
3 3 - 5 3 - 4 |
152 154 84 152 127 84 132 |
15 11 -- 7 17 -- 6 |
12 12 9 10 10 14 8 |
2 2 - 3 3 - 1 |
38 40 29 48 43 18 40 |
7 7 - 10 6 - 9 |
2-AA |
+ |
182 |
33 |
800 |
163 |
86 |
24 |
472 |
105 |
10% Water DMSO Methanol |
+ + + |
15 16 -- |
- 3 - |
102 132 150 |
- 5 - |
5 10 -- |
- 1 - |
46 39 -- |
- 4 - |
2-AA |
+ |
208 |
48 |
1408 |
216 |
314 |
14 |
754 |
369 |
2) Ethylene glycol dimethylether
Summary of historical negative and positive controls of experiments performed from July to December 1991 using mean value presented as medians (Z) and semi-Q range (QR)
Compound and S9 Mix |
Strain |
||||||||
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
||||||
Z |
QR |
Z |
QR |
Z |
QR |
Z |
QR |
||
Water Buffer DMSO DMF Methanol Ethanol Acetone EGDE2 |
- - - - - - - - |
12 13 12 7 10 12 12 14 |
3 2 3 - 1 4 2 3 |
89 97 92 75 84 80 87 107 |
10 10 15 - 11 8 6 22 |
9 8 9 7 8 8 8 8 |
3 1 1 - 1 3 1 1 |
27 25 24 17 25 23 26 26 |
4 2 4 - 3 4 4 5 |
Na-azide NF 4-NPDA |
- - - |
605 |
122 |
339 |
52 |
53 |
9 |
79 |
17 |
30% Water Buffer DMSO DMF Methanol Ethanol Acetone EGDE2 |
+ + + + + + + + |
19 17 19 11 25 18 18 22 |
4 - 3 - - 5 2 4 |
138 159 130 142 134 119 111 144 |
21 - 11 - - 19 9 11 |
13 13 10 9 12 11 13 13 |
2 - 2 - - 2 - 3 |
33 38 33 32 37 37 28 32 |
4 - 4 - - 2 11 3 |
2-AA |
+ |
164 |
38 |
727 |
139 |
91 |
32 |
520 |
161 |
10% Water Buffer DMSO DMF Methanol Ethanol Acetone EGDE2 |
+ + + + + + + + |
16 14 16 15 16 19 17 20 |
4 - 2
- 3 - 2 |
113 94 118 114 111 94 112 153 |
18 - 14 6 - 6 - 11 |
10 10 10 11 9 12 11 11 |
3 - 3 - - 2 - 1 |
33 34 31 21 29 32 32 34 |
5 - 3 - - 2 - 5 |
2-AA |
+ |
197 |
50 |
1431 |
260 |
304 |
116 |
1097 |
207 |
2) Ethylene glycol dimethylether
Summary of historical negative and positive controls of experiments performed from January to June 1992 using mean value presented as medians (Z) and semi-Q range (QR)
Compound and S9 Mix |
Strain |
||||||||
TA 1535 |
TA 100 |
TA 1537 |
TA 98 |
||||||
Z |
QR |
Z |
QR |
Z |
QR |
Z |
QR |
||
Water DMSO DMF Ethanol Acetone EGDE2 |
- - - - - - |
16 15 13 15 13 17 |
2 4 3 4 2 - |
93 81 68 91 59 69 |
11 9 4 15 12 - |
9 9 7 7 7 7 |
2 1 1 2 1 - |
23 23 19 25 19 14 |
4 4 3 2 1 - |
Na-azide NF 4-NPDA |
- - - |
660 |
147 |
285 |
65 |
52 |
7 |
74 |
13 |
30% Water DMSO DMF Ethanol Acetone EGDE2 |
+ + + + + + |
23 22 18 25 17 19 |
4 5 2 - 3 - |
124 120 89 145 79 119 |
18 20 5 - 9 - |
12 12 11 9 8 8 |
1 2 1 - 2 - |
31 31 27 38 24 18 |
6 5 1 - 4 - |
2-AA |
+ |
151 |
17 |
669 |
208 |
62 |
13 |
382 |
111 |
10% Water DMSO DMF Ethanol Acetone EGDE2 |
+ + + + + + |
20 17 17 24 15 11 |
4 3 - 4 3 - |
118 111 87 98 69 48 |
17 15 - 5 7 - |
12 10 9 9 12 11 |
3 2 - 2 6 - |
33 32 34 37 29 22 |
5 4 - 5 5 - |
2-AA |
+ |
159 |
35 |
1148 |
332 |
246 |
21 |
1126 |
292 |
2) Ethylene glycol dimethylether
Applicant's summary and conclusion
- Conclusions:
- The test item was considered to be non-mutagenic without and with an exogenous metabolic activation system in the plate incorporation as well as in the Prival modification of the Salmonella/microsome test. The substance is not to be classified in accordance with CLP criteria.
- Executive summary:
Reactive Red 158 was investigated for mutagenic effects using the Salmonella/ microsome plate incorporation test in doses of up to 5000 µg per plate on four Salmonella typhimurium LT2 mutants. These comprised the histidine-auxotrophic strains TA 1535, TA 100, TA 153 and TA 98.
In the plate incorporation assay doses of up to and including 200 µg per plate did not cause any bacteriotoxic effects. Total bacteria counts remained unchanged and no inhibition of growth was observed. At higher doses, the substance had a weak, strain-specific bacteriotoxic effect, so that this range could nevertheless be used for assessment purposes.
In the plate incorporation assay evidence of mutagenic activity of Reactive Red 158 was not seen. No biologically relevant increase in the mutant count, in comparison with the negative controls, was observed. The positive controls sodium azide, nitrofurantoin, 4-nitro1,2-phenylene diamine and 2-aminoanthracene had a marked mutagenic effect, as was seen by a biologically relevant increase in mutant colonies compared to the corresponding negative controls.
In addition, Reactive Red 158 was investigated in the Salmonella/microsome test, modified with S9 mix according to Prival and Mitchell, for point mutagenic effects in doses of up to 5000 μg per tube on the same strains. Without S9 mix preincubation was used.
Doses of up to and including 40 μg per tube did not cause any bacteriotoxic effects: Total bacteria counts remained unchanged and no inhibition of growth was observed. A higher doses, the substance had a strain-specific bacterotoxic effect, so that this range could only be used to a limited extent up to 5000 μg per tube for assessment purposes.
Evidence of mutagenic activity of Reactive Red 158 was not seen. No biologically relevant increase in the mutant count, in comparison with the negative controls, was observed.
The positive controls sodium azide, nitrofurantoin, 4-nitro-1,2-phenylene diamine, benzidine, Congo red and 2-aminoanthracene had a marked mutagenic effect, as was seen by a biologically relevant increase in mutant colonies compared to the corresponding negative controls.
Therefore, Reactive Red 158 was considered to be non-mutagenic without and with S9 mix in the plate incorporation as well as in the Prival modification of the Salmonella/microsome test.
The substance is not classified in accordance with CLP criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.